Search Results 511-520 of 17364 for Teratogenic
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
TNG462-C102 is a Phase 1/2, open-label, multicenter study designed to determine the safety, tolerability, PK, PD, and preliminary antineoplastic activity of ...
Learn about the experts and services, including awake brain surgery, available for the diagnosis and treatment of brain and central nervous system tumors.
Mr. Ma was misdiagnosed at home and experienced a few unsuccessful treatments. His daughter brought Mr. Ma to Mayo Clinic where the patient's rare and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Study of CG0070 Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin · Overview · Participation eligibility.
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
Gangar K, Selladurai R, Rajjo T, Maxson J, Kumar S, Lynch B, Kaufman T, Cole K, Thacher TD. Relationship of growth in the first five years of life and risk ...
About this study. The primary purpose of this study is to collect Biospecimens from patients who developed chemotherapy related cardiac toxicity (CRCT) and ...
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.